Search This Blog

1

Labels

Cancer (150) Breast (38) Study (38) Health (32) Patients (31) Treatment (27) Could (23) Therapy (19) Research (17) Against (12) Blood (11) Disease (11) linked (11) Diabetes (10) Early (10) Prevent (10) Survival (10) Treatments (7) higher (7) surgery (7) Might (6) Prostate (6) Tumors (6) During (5) Effects (5) Growth (5) Chemotherapy (4) Drinking (4) Prevention (4) Obama (3) Obesity (3) Without (3) associated (3) Experts (2) Important (2) Infection (2) About (1) Analysis (1) Causes (1) Eliminate (1) stroke (1)

AD

Showing posts with label Links. Show all posts
Showing posts with label Links. Show all posts

Tuesday, January 7, 2014

'Ardi' skull reveals links to human lineage

Jan. 6, 2014 — One of the most hotly debated issues in current human origins research focuses on how the 4.4 million-year-old African species Ardipithecus ramidus is related to the human lineage. "Ardi" was an unusual primate. Though it possessed a tiny brain and a grasping big toe used for clambering in the trees, it had small, humanlike canine teeth and an upper pelvis modified for bipedal walking on the ground.

Scientists disagree about where this mixture of features positions Ardipithecus ramidus on the tree of human and ape relationships. Was Ardi an ape with a few humanlike features retained from an ancestor near in time (between 6 and 8 million years ago, according to DNA evidence) to the split between the chimpanzee and human lines? Or was it a true relative of the human line that had yet to shed many signs of its remote tree-dwelling ancestry?

New research led by Arizona State University paleoanthropologist William Kimbel confirms Ardi's close evolutionary relationship to humans. Kimbel and his collaborators turned to the underside (or base) of a beautifully preserved partial cranium of Ardi. Their study revealed a pattern of similarity that links Ardi to Australopithecus and modern humans, but not to apes.

The research appears in the Jan. 6-10 online edition of Proceedings of the National Academy of Sciences. Kimbel is director of the ASU Institute of Human Origins, a research center of the College of Liberal Arts and Sciences in the School of Human Evolution and Social Change. Joining ASU's Kimbel as co-authors are Gen Suwa (University of Tokyo Museum), Berhane Asfaw (Rift Valley Research Service, Addis Ababa), Yoel Rak (Tel Aviv University) and Tim White (University of California at Berkeley).

White's field-research team has been recovering fossil remains of Ardipithecus ramidus in the Middle Awash research area, Ethiopia since the 1990s. The most recent study of the Ardi skull, led by Suwa, was published in Science in 2009, whose work (with the Middle Awash team) first revealed humanlike aspects of its base. Kimbel co-leads the team that recovered the earliest known Australopithecus skulls from the Hadar site, home of the "Lucy" skeleton, in Ethiopia.

"Given the very tiny size of the Ardi skull, the similarity of its cranial base to a human's is astonishing," says Kimbel.

The cranial base is a valuable resource for studying phylogenetic, or natural evolutionary relationships, because its anatomical complexity and association with the brain, posture and chewing system have provided numerous opportunities for adaptive evolution over time. The human cranial base, accordingly, differs profoundly from that of apes and other primates.

In humans, the structures marking the articulation of the spine with the skull are more forwardly located than in apes, where the base is shorter from front to back and the openings on each side for passage of blood vessels and nerves are more widely separated.

These shape differences affect the way the bones are arranged on the skull base, such that it is fairly easy to tell apart even isolated fragments of ape and human basicrania.

Ardi's cranial base shows the distinguishing features that separate humans and Australopithecus from the apes. Kimbel's earlier research (with collaborator Rak) had shown that these human peculiarities were present in the earliest known Australopithecus skulls by 3.4 million years ago.

The new work expands the catalogue of anatomical similarities linking humans, Australopithecus and Ardipithecus on the tree of life, and shows that the human cranial base pattern is at least a million years older than Lucy's species, A. afarensis.

Paleoanthropologists generally fall into one of two camps on the cause of evolutionary changes in the human cranial base. Was it the adoption of upright posture and bipedality that caused a shift in the poise of the head on the vertebral column? If so, does the humanlike cranial base of Ar. ramidus confirm postcranial evidence for partial bipedality in this species? Or, do the changes tell us about the shape of the brain (and of the base on which it sits), perhaps an early sign of brain reorganization in the human lineage? Both alternatives will need to be re-evaluated in light of the finding that Ardi does indeed appear to be more closely related to humans than to chimpanzees.

"The Ardi cranial base fills some important gaps in our understanding of human evolution above the neck," adds Kimbel. "But it also opens up a host of new questions . . . just as it should!"


View the original article here

Monday, December 2, 2013

Large study links nut consumption is reduced mortality.

Who ate nuts daily of the largest study of its kind, a handful were 20 percent less and were people who did not consume nuts so the Dana contains the report published in the New England Journal of medicine, say scientists from the Harvard School of Farber Cancer Institute, Brigham and women's Hospital and public health more than die by any cause over a period of 30 years is even better news. Regular nut-eaters found is thinner than people who did not eat the nuts, may find that eating more nuts will need to reduce the widespread concerns on obesity.

View the original article here

Monday, September 9, 2013

NIH study links Hodgkin lymphoma treatment to possible risk of stomach cancer

AppId is over the quota
AppId is over the quota

Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health. The study appeared Aug. 26, 2013, in the Journal of Clinical Oncology.

Hodgkin lymphoma is a cancer of the immune system. It is one of the most common cancers among adolescents and young adults in the United States. Major advances in treatment for this cancer, such as different types of chemotherapy and more targeted radiotherapy, have led to improvements in survival. According to data from NCI’s Surveillance, Epidemiology and End Results Program, the five-year survival rate for Hodgkin’s from 1975 to1977 was 72 percent; from 2003 to 2009 it was 88 percent.

Pink stained pathology slide of adenocarcinoma, the most common type of stomach cancer, with cancer cells staining a darker shade of pink

While the cure rate for this disease is high, there is a risk of developing secondary malignancies, such as breast cancer, lung cancer and stomach cancer. Past studies have linked Hodgkin lymphoma radiation and chemotherapy treatments with stomach cancer risk, but those studies have been limited in scope. To better understand the relationship between Hodgkin lymphoma treatments and subsequent stomach cancer risk, Lindsay M. Morton, Ph.D., NCI Division of Cancer Epidemiology and Genetics, and her colleagues analyzed data from the Netherlands, Denmark, Finland, Norway, Sweden, the United States and Canada. Their analyses included nearly 20,000 survivors of the disease who were diagnosed between 1953 and 2003.

Of 17,477 Hodgkin lymphoma cases examined, the researchers identified 89 survivors who later developed stomach cancer. From patient medical records, they obtained detailed information on treatments, which they used to estimate radiation doses to the stomach and to calculate the doses and types of chemotherapy that were used to treat the survivors’ Hodgkin lymphoma. By comparing the treatments received by the survivors who developed stomach cancer with the treatments received by survivors who did not develop stomach cancer, the investigators were able to determine the risks of developing stomach cancer from the treatment for Hodgkin lymphoma.

Their analysis showed that the risk of stomach cancer increased with increasing doses of radiation to the stomach. Patients who received the highest radiation doses had a risk of stomach cancer nearly threefold greater than patients who received the lowest doses. Further, the risks associated with radiation were even higher for survivors who also received the alkylating agent procarbazine, a type of chemotherapy known to cause damage to DNA. Stomach cancer risks were highly dependent on the doses of both radiation and procarbazine. This study is the first to provide clear evidence of a strong interaction between chemotherapy and radiotherapy on risk of subsequent stomach cancer.

The study also suggested that stomach cancer risk was increased for patients who received a similar alkylating agent, dacarbazine, which is commonly used to treat Hodgkin lymphoma today. However, more research on this outcome is needed because few patients in this study received dacarbazine. No other alkylating agent evaluated in this study was associated with an increased risk of stomach cancer.?

“Our study adds strong support to the growing concern that stomach cancer is a rare but important adverse late effect of treatment for Hodgkin lymphoma,” said Morton. “Because Hodgkin lymphoma patients commonly receive treatment in their 20s and 30s, many of the stomach cancers arise before age 50, nearly 20 years earlier than is typical for newly diagnosed patients who have never had cancer. Clinicians who follow these survivors should be alert to patient complaints related to the gastrointestinal tract.”

This work was supported by the Intramural Research Program of NCI as well as through NCI-issued contracts.

# # #

Reference: ?Morton LM, Dores GM, et al. Stomach cancer risk after treatment for Hodgkin lymphoma. JCO. August 26, 2013.? DOI: 10.1200/JCO.2013.50.6832.


View the original article here